Ligne de temps
Vincent Enouf
Directeur(trice) Adjoint(e) de Centre National de Référence
30 sept. 2024
publication
Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP.3.3 From Approved Monoclonal Antibodies
Lire plus26 sept. 2024
publication
Levels and functionality of Pacific Islanders’ hybrid humoral immune response to BNT162b2 vaccination and delta/omicron infection: A cohort study in New Caledonia.
Lire plus01 sept. 2024
publication
Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine
Lire plus26 août 2024
publication
Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study.
Lire plus01 juil. 2024
publication
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans
Lire plus01 juil. 2024
publication
COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.
Lire plus23 mai 2024
publication
Serological responses against seasonal influenza viruses in patients with multiple myeloma treated or untreated with daratumumab after two doses of tetravalent vaccine.
Lire plus28 mars 2024
publication
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
Lire plus01 mars 2024
publication
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Lire plus22 févr. 2024
publication
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024
Lire plus01 févr. 2024
publication
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.
Lire plus01 janv. 2024
publication
Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study
Lire plus01 janv. 2024
publication
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
Lire plus01 nov. 2023
publication
Seasonal and inter‐seasonal RSV activity in the European Region during the COVID‐19 pandemic from autumn 2020 to summer 2022
Lire plus01 nov. 2023
publication
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Lire plus25 août 2023
publication
Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemic
Lire plus01 juin 2023
publication
Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique
Lire plus01 juin 2023
publication
Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique.
Lire plus02 févr. 2023
publication
Investigations on SARS-CoV-2 and other coronaviruses in mink farms in France at the end of the first year of COVID-19 pandemic
Lire plus02 févr. 2023
publication
Investigations on SARS-CoV-2 and other coronaviruses in mink farms in France at the end of the first year of COVID-19 pandemic.
Lire plus01 janv. 2023
publication
Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemic.
Lire plus11 nov. 2022
publication
Capturing SARS-CoV-2 from patient samples with low viral abundance: a comparative analysis
Lire plus01 sept. 2021
publication
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France.
Lire plus20 janv. 2021
publication
Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification
Lire plus02 sept. 2020
publication
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
Lire plus04 août 2020
publication
Highly performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification.
Lire plus01 juil. 2020
publication
Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020.
Lire plus31 janv. 2020
28 janv. 2020
18 juin 2019
04 juil. 2017
24 mai 2017
news
Emerging diseases: a highly mutant strain of the Elizabethkingia bacterium caused an outbreak in Wisconsin
Lire plus10 oct. 2016
news
A population biology study of Listeria ushers in a new era in listeriosis surveillance
Lire plus06 juin 2016
27 juil. 2015
01 juil. 2015
publication
Early estimates of 2014/15 seasonal influenza vaccine effectiveness in preventing influenza-like illness in general practice using the screening method in France
Lire plus12 mai 2015
publication
Erratum to: Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review
Lire plus29 janv. 2015
publication
Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype
Lire plus29 janv. 2015
publication
Genetic Adaptation of Influenza A Viruses in Domestic Animals and Their Potential Role in Interspecies Transmission: A Literature Review
Lire plus08 mai 2014
publication
Influenza at the animal-human interface: a review of the literature for virological evidence of human infection with swine or avian influenza viruses other than A(H5N1)
Lire plus13 nov. 2013
publication
Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility
Lire plus03 juil. 2013
publication
Complications and factors associated with severity of influenza in hospitalized children and adults during the pandemic wave of A(H1N1)pdm2009 infections–the Fluco French cohort
Lire plus13 juin 2013
publication
First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013
Lire plus30 mai 2013
publication
Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission
Lire plus31 janv. 2013
publication
Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe
Lire plus24 août 2012
publication
I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y
Lire plus14 août 2012
publication
Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections
Lire plus09 juin 2012
publication
HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains
Lire plus22 mars 2012
publication
Incidence of H1N1 2009 virus infection through the analysis of paired plasma specimens among blood donors, France
Lire plus20 janv. 2012
publication
Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008-2009 winter
Lire plus15 déc. 2011
publication
S-OtrH3N2 viruses: use of sequence data for description of the molecular characteristics of the viruses and their relatedness to previously circulating H3N2 human viruses
Lire plus27 oct. 2011
publication
Highly heterogeneous temperature sensitivity of 2009 pandemic influenza A(H1N1) viral isolates, northern France
Lire plus30 juin 2011
29 juin 2011
publication
Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes
Lire plus01 avr. 2011
publication
Monitoring epidemic viral respiratory infections using one-step real-time triplex RT-PCR targeting influenza A and B viruses and respiratory syncytial virus.
Lire plus09 déc. 2010
publication
Initial surveillance of 2009 influenza A(H1N1) pandemic in the European Union and European Economic Area, April-September 2009
Lire plus02 nov. 2010
publication
Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial
Lire plus01 oct. 2009
publication
Molecular epidemiology of clade 1 influenza A viruses (H5N1), southern Indochina peninsula, 2004-2007
Lire plus22 juil. 2009
publication
Kinetics of nasopharyngeal shedding of novel H1N1 (swine-like) influenza A virus in an immunocompetent adult under oseltamivir therapy.
Lire plus11 juin 2009
publication
Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries
Lire plus27 mai 2009
publication
[Glycopeptide-resistant enterococci carriage: Are actual isolation and identification techniques sufficient?]
Lire plus01 avr. 2009
01 janv. 2009
25 juil. 2008
publication
Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir.
Lire plus14 févr. 2007
publication
Acute bilateral uveitis associated with an active human herpesvirus-6 infection
Lire plus01 sept. 2006
publication
Identification of genotype 1 hepatitis E virus in samples from swine in Cambodia
Lire plus01 août 2006
publication
Validation of single real-time TaqMan PCR assay for the detection and quantitation of four major genotypes of hepatitis E virus in clinical specimens
Lire plus01 déc. 2005
publication
Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad
Lire plus01 nov. 2004
01 juin 2003
publication
Interactions of rotavirus VP4 spike protein with the endosomal protein Rab5 and the prenylated Rab acceptor PRA1
Lire plus01 mai 2002
publication
Rafts promote assembly and atypical targeting of a nonenveloped virus, rotavirus, in Caco-2 cells
Lire plus01 avr. 2001
publication